玉野井冬彦 (Fuyuhiko Tamanoi) - マイポータル

基本情報

所属: 京都大学

ORCID iD: https://orcid.org/0000-0002-4220-6408
J-GLOBAL ID: 201701017039840970
researchmap会員ID: 7000019526

研究分野

ライフサイエンス / 腫瘍生物学 /

論文

139

Organosilica nanoparticles containing sodium borocaptate (BSH) provide new prospects for boron neutron capture therapy (BNCT): efficient cellular uptake and enhanced BNCT efficacy.

Mathilde Laird, Kotaro Matsumoto, Yuya Higashi, Aoi Komatsu, Art Raitano, Kendall Morrison, Minoru Suzuki, Fuyuhiko Tamanoi

Nanoscale advances 5(9) 2537-2546 2023年5月2日
Tumor Accumulation of PIP-Based KRAS Inhibitor KR12 Evaluated by the Use of a Simple, Versatile Chicken Egg Tumor Model

Yuya Higashi, Shuji Ikeda, Kotaro Matsumoto, Shinsuke Satoh, Aoi Komatsu, Hiroshi Sugiyama, Fuyuhiko Tamanoi

Cancers 14(4) 951-951 2022年2月14日
Iodine containing porous organosilica nanoparticles trigger tumor spheroids destruction upon monochromatic X-ray irradiation: DNA breaks and K-edge energy X-ray

Yuya Higashi, Kotaro Matsumoto, Hiroyuki Saitoh, Ayumi Shiro, Yue Ma, Mathilde Laird, Shanmugavel Chinnathambi, Albane Birault, Tan Le Hoang Doan, Ryo Yasuda …

Scientific Reports 11(1) 2021年12月
The CAM Model for CIC-DUX4 Sarcoma and Its Potential Use for Precision Medicine.

Aoi Komatsu, Kotaro Matsumoto, Yuki Yoshimatsu, Yooksil Sin, Arisa Kubota, Tomoki Saito, Ayaka Mizumoto, Shinya Ohashi, Manabu Muto, Rei Noguchi …

Cells 10(10) 2021年10月1日
Designing Mesoporous Silica Nanoparticles to Overcome Biological Barriers by Incorporating Targeting and Endosomal Escape

Miguel Gisbert-Garzaran, Daniel Lozano, Kotaro Matsumoto, Aoi Komatsu, Miguel Manzano, Fuyuhiko Tamanoi, Maria Vallet-Regi

ACS Applied Materials and Interfaces 13(8) 9656-9666 2021年3月3日
Construction of Boronophenylalanine-Loaded Biodegradable Periodic Mesoporous Organosilica Nanoparticles for BNCT Cancer Therapy

Fuyuhiko Tamanoi, Shanmugavel Chinnathambi, Mathilde Laird, Aoi Komatsu, Albane Birault, Takushi Takata, Tan Le-Hoang Doan, Ngoc Xuan Dat Mai, Arthur Raitano, Kendall Morrison …

International Journal of Molecular Sciences 22(5) 2251-2251 2021年2月24日査読有り筆頭著者
Facile synthesis of biodegradable mesoporous functionalized-organosilica nanoparticles for enhancing the anti-cancer efficiency of cordycepin

Ngoc Xuan Dat Mai, Uyen-Chi Nguyen Le, Linh Ho Thuy Nguyen, Hanh Thi Kieu Ta, Ha Van Nguyen, Tri Minh Le, Thang Bach Phan, Lien-Thuong Thi Nguyen, Fuyuhiko Tamanoi, Tan Le Hoang Doan

Microporous and Mesoporous Materials 315 110913-110913 2021年2月査読有り
Recent Development to Explore the Use of Biodegradable Periodic Mesoporous Organosilica (BPMO) Nanomaterials for Cancer Therapy

Shanmugavel Chinnathambi, Fuyuhiko Tamanoi

Pharmaceutics 12(9) 890-890 2020年9月18日
Studies on the Exposure of Gadolinium Containing Nanoparticles with Monochromatic X-rays Drive Advances in Radiation Therapy.

Fuyuhiko Tamanoi, Kotaro Matsumoto, Tan Le Hoang Doan, Ayumi Shiro, Hiroyuki Saitoh

Nanomaterials (Basel, Switzerland) 10(7) 2020年7月9日査読有り筆頭著者
Biodegradable Periodic Mesoporous Organosilica (BPMO) Loaded with Daunorubicin: A Promising Nanoparticle-Based Anticancer Drug.

Ngoc Xuan Dat Mai, Albane Birault, Kotaro Matsumoto, Hanh Kieu Thi Ta, Soontaree Grace Intasa-Ard, Kendall Morrison, Phan Bach Thang, Tan Le Hoang Doan, Fuyuhiko Tamanoi

ChemMedChem 15(7) 593-599 2020年4月3日査読有り
Recent excitements in the study of the CAM assay.

Fuyuhiko Tamanoi

The Enzymes 46 1-9 2019年10月査読有り
Destruction of tumor mass by gadolinium-loaded nanoparticles irradiated with monochromatic X-rays: Implications for the Auger therapy.

Kotaro Matsumoto, Hiroyuki Saitoh, Tan Le Hoang Doan, Ayumi Shiro, Keigo Nakai, Aoi Komatsu, Masahiko Tsujimoto, Ryo Yasuda, Tetsuya Kawachi, Toshiki Tajima …

Scientific reports 9(1) 13275-13275 2019年9月30日査読有り
Patient Derived Chicken Egg Tumor Model (PDcE Model): Current Status and Critical Issues.

Aoi Komatsu, Kotaro Matsumoto, Tomoki Saito, Manabu Muto, Fuyuhiko Tamanoi

Cells 8(5) 2019年5月10日査読有り
Relationship between the glutathione-responsive degradability of thiol-organosilica nanoparticles and the chemical structures

Doura Tomoshiro, Nishio Tadashi, Tamanoi Fuyuhiko, Nakamura Michihiro

JOURNAL OF MATERIALS RESEARCH 34(7) 1266-1278 2019年4月15日査読有り
がんの個別化医療を切り拓く鶏卵モデル

玉野井冬彦, 遠藤良夫, 宇都義浩, 楠橋由貴, 二若真菜, 松本光太郎

実験医学 37(1) 88-92 2019年1月査読有り
Biodegradability of Disulfide-Organosilica Nanoparticles Evaluated by Soft X-ray Photoelectron Spectroscopy: Cancer Therapy Implications

Harutaka Mekaru, Akitaka Yoshigoe, Michihiro Nakamura, Tomohiro Doura, Fuyuhiko Tamanoi

ACS APPLIED NANO MATERIALS 2(1) 479-488 2019年1月査読有り
Miniaturization of thiol-organosilica nanoparticles induced by an anionic surfactant

Tomohiro Doura, Fuyuhiko Tamanoi, Michihiro Nakamura

Journal of Colloid and Interface Science 526 51-62 2018年9月15日査読有り
Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer.

Binh Thanh Vu, Sophia Allaf Shahin, Jonas Croissant, Yevhen Fatieiev, Kotaro Matsumoto, Tan Le-Hoang Doan, Tammy Yik, Shirleen Simargi, Altagracia Conteras, Laura Ratliff …

Scientific reports 8(1) 8524-8524 2018年6月4日査読有り
Hyaluronic acid conjugated nanoparticle delivery of siRNA against TWIST reduces tumor burden and enhances sensitivity to cisplatin in ovarian cancer.

Shahin SA, Wang R, Simargi SI, Contreras A, Parra Echavarria L, Qu L, Wen W, Dellinger T, Unternaehrer J, Tamanoi F …

Nanomedicine : nanotechnology, biology, and medicine 14(4) 1381-1394 2018年4月査読有り
Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women's breast cancer tumors.

Faridi N, Bathaie SZ, Abroun S, Farzaneh P, Karbasian H, Tamanoi F, Mohagheghi MA

Cytotechnology 70(2) 625-639 2018年4月査読有り

もっとみる

MISC

がんの鶏卵モデル

小松葵, 松本光太郎, 玉野井冬彦

患者由来のがんモデルを用いたがん研究実践ガイド実験医学別冊 246-254 2019年10月
Treatment of metastatic breast cancer using two nanoparticles combined with siRNA targeting Twist1 to inhibit EMT

James B. Finlay, Cai M. Roberts, Gina Lowe, Ling Peng, Jeff I. Zink, Fuyuhiko Tamanoi, Carlotta A. Glackin

CANCER RESEARCH 75 2015年5月
Interruption of K-Ras/PAK1/Crk pathway has a dramatic anti-tumor effect in NSCLC

Fariborz (Fred) Mortazavi, Jie Lu, Aljilani Amir, Ryan Phan, Fuyuhiko Tamanoi

MOLECULAR CANCER RESEARCH 12 2014年12月
Light-controllable nano-drug delivery system with deep tissue penetrating ability for cancer therapy with two-photon-triggered nanoimpellers

Jie Lu, Jonas Croissant, Jean-Olivier Jean-Olivier Durand, Tania Guardado-Alvarez, Jeffrey I. Zink, Fuyuhiko Tamanoi

CANCER RESEARCH 74(19) 2014年10月
Recent progress in the study of the Rheb family GTPases

Jeffrey J. Heard, Valerie Fong, S. Zahra Bathaie, Fuyuhiko Tamanoi

CELLULAR SIGNALLING 26(9) 1950-1957 2014年9月
Nanomachine-controlled cargo release monitored in single living cells

Bryana L. Henderson, Yuen A. Lau, Eunshil Choi, Jie Lu, Fuyuhiko Tamanoi, Jeffrey I. Zink

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 241 2011年3月
Real-time rate measurement of cargo release by nanoimpellers in a single cell

Yuen A. Lau, Bryana Henderson, Jie Lu, Fuyuhiko Tamanoi, Jeff I. Zink

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 241 2011年3月
Conservation of the Tsc/Rheb/TORC1/S6K/S6 signaling in fission yeast

Akio Nakashima, Fuyuhiko Tamanoi

Enzymes 28(C) 167-187 2010年招待有り
Blocking Rheb posttranslational processing and localization for cancer treatment

Ariella Hanker, Rhonda Wilder, Elizabeth Henske, Fuyuhiko Tamanoi, Adrienne Cox, Channing Der

CANCER RESEARCH 69 2009年5月
In vivo antitumor effect of a novel inhibitor of protein geranylgeranyltransferase I

Jie Lu, Lai Chan, Hannah Fiji, Russell Dahl, Ohyun Kwon, Fuyuhiko Tamanoi

CANCER RESEARCH 69 2009年5月
Chemical biology/chemical genetics/chemical genomics: Importance of chemical library

Fumihiko Kugawa, Masaru Watanabe, Fuyuhiko Tamanoi

Chem-Bio Informatics Journal 7(3) 49-68 2007年
NEW ACTIVATED RAS2 MUTATIONS IDENTIFIED IN SACCHAROMYCES-CEREVISIAE

BA WILSON, M KHALIL, F TAMANOI, JF CANNON

ONCOGENE 8(12) 3441-3445 1993年12月

講演・口頭発表等

Gadolinium-loaded mesoporous silica nanoparticles trigger destruction of tumor spheroids upon irradiation with monochromatic X-ray

Yue Ma, Fuyuhiko Tamanoi

The 8th Japan-China Symposium on Nanomedicine 2021年6月11日招待有り
A new radiation therapy by combining gadolinium-loaded nanoparticles and monochromatic X-ray

Fuyuhiko Tamanoi

E-MRS Spring meeting 2021 2021年6月3日招待有り
量子ビームとナノ材料研究により拓かれる量子ナノ医療研究

玉野井冬彦

ナノ学会第18回大会 2020年5月
Nanomedicine and Cancer Therapy

Fuyuhiko Tamanoi

Kyoto University-Academia Sinica Bilateral Symposium 2019年12月18日招待有り
Novel radiation therapy employing monochromatic X-ray and nanoparticles

Fuyuhiko Tamanoi

First QNM-iCeMS Symposium: Exploring New Approaches for Cancer Therapy 2019年12月13日招待有り
Developing a Novel radiation therapy involving monochromatic X-ray and Auger effect

Fuyuhiko Tamanoi

13th International Symposium on Nanomedicine 2019年12月6日招待有り
Developing a novel radiation therapy by employing monochromatic X-ray and nanoparticles

Fuyuhiko Tamanoi

International Symposium: New Technology for Diagnosis and Therapeutics of Cancer 2019年12月2日招待有り
Chicken egg tumor model and boron neutron capture therapy (BNCT)

Fuyuhiko Tamanoi

Annual Retreat, Kyoto University 2019年9月22日招待有り
A new radiation therapy emerging from the convergence of nanotechnology and particle physics

Fuyuhiko Tamanoi

HeKKSaGOn 6th German-Japanese University Presidents’ Conference 2019年9月12日招待有り
Patient-derived chicken egg tumor model (PDcE model)

玉野井冬彦

講演会：患者由来がんモデル～基礎研究から臨床応用まで～ 2019年8月2日招待有り
Patient-derived tumor models and KRAS inhibitors

Fuyuhiko Tamanoi

FASEB Summer Research Conference 2019年6月24日招待有り
Efficacy of biodegradable PMO to inhibit tumor growth in animal models

Fuyuhiko Tamanoi

The 7th China-Japan Symposium on Nanomedicine 2019年5月25日招待有り
Patient-derived Chicken Egg Tumor Model, Precision Medicine and Nanoparticle-mediated Cancer Therapy

玉野井冬彦

Kyoto Winter School "Quantifying Dynamics of Life" 2019年3月26日招待有り
Patient-derived chicken egg tumor modeland tailor-made medicine

玉野井冬彦

The SPIRITS International Symposium-2019 "Regulation of cell fate and disease treatment" 2019年1月28日招待有り
Tumor Targeting of Mesoporous Silica Nanoparticles Characterized by Using Chicken Egg Tumor Model

玉野井冬彦

2018 Taiwan-Japan-Korea Trilateral Conference on Nanomedicine 2018年12月14日招待有り
Boron Neutron Capture Therapy and Nanotechnology

玉野井冬彦

12th International Symposium on Nanomedicine 2018年12月7日
Boron Neutron Capture Therapy and Nanotechnology

玉野井冬彦

Kyoto-UCLA, Harnessing Physical Forces for Medical Applocations Symposium 2018年11月
癌の鶏卵モデル：患者由来がんモデルとナノ治療開発系としての可能性

玉野井冬彦

新しい治療法の開発を目指す患者由来がんモデル 2018年6月28日招待有り
Cancer therapy using mesoporous silica nanoparticles

玉野井冬彦

Mesoporous Materials: 1991-2018. International Symposium 2018年4月10日招待有り

共同研究・競争的資金等の研究課題

単色X線とナノ粒子を用いたがんの新規放射線治療

日本学術振興会科学研究費助成事業基盤研究(A) 2020年4月 - 2023年3月

玉野井冬彦, 齋藤寛之
新規のホウ素含有ナノ粒子の構築とBNCTへの応用

日本学術振興会科学研究費助成事業国際共同研究加速基金(帰国発展研究) 2017年 - 2019年

玉野井冬彦, 鈴木実, 齋藤寛之

玉野井冬彦

基本情報

研究分野

論文

MISC

講演・口頭発表等

共同研究・競争的資金等の研究課題

メニュー

共著者の一覧